Showing results (101-110 of 172) with videos related to
Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 25, 2017
Immune Correlates of GM-CSF and Melanoma Peptide Vaccination in a Randomized Trial for the Adjuvant Therapy of Resected High-Risk Melanoma (E4697)Lisa H Butterfield, Fengmin Zhao, Sandra Lee, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2015
Randomized, Placebo-Controlled, Phase III Trial of Yeast-Derived Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus Peptide Vaccination Versus GM-CSF Plus Peptide Vaccination Versus Placebo in Patients With No Evidence of Disease After Complete Surgical Resection of Locally Advanced and/or Stage IV Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E4697)David H Lawson, Sandra Lee, Fengmin Zhao, et al.Melanoma Research|March 11, 2026
Insights into inherited genetic variations and genetic ancestry of patients with high-risk melanomaAhmad A Tarhini, Mohammad Ali Khaksar, Zhihua Chen, et al.Journal for Immunotherapy of Cancer|June 19, 2026
Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanomaAhmad A Tarhini, Mohammad Ali Khaksar, Zhihua Chen, et al.Cancers|October 27, 2022
Sentinel Lymph Node Gene Expression Signature Predicts Recurrence-Free Survival in Cutaneous MelanomaLilit Karapetyan, William Gooding, Aofei Li, et al.Annals of Surgical Oncology|August 7, 2021
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node DissectionKristy K Broman, Deepti Bettampadi, Jaileene Pérez-Morales, et al.ESMO Open|February 8, 2021
A matching-adjusted indirect comparison of combination nivolumab plus ipilimumab with BRAF plus MEK inhibitors for the treatment of BRAF-mutant advanced melanoma<sup>☆</sup>A A Tarhini, K Toor, K Chan, et al.Human Gene Therapy|September 30, 2010
A phase I study of concurrent chemotherapy (paclitaxel and carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase plasmid liposome protection in patients with locally advanced stage III non-small-cell lung cancerAhmad A Tarhini, Chandra P Belani, James D Luketich, et al.Journal for Immunotherapy of Cancer|April 25, 2019
Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanomaLisa H Butterfield, Lazar Vujanovic, Patricia M Santos, et al.Cancer Reports (Hoboken, N.J.)|January 8, 2024
Comparing the rate of immunotherapy treatment change due to toxicity by sexKevin J Chua, Shane Kronstedt, Alain Kaldany, et al.Pageof 18